GlassScriptPhysician profile
Derrick W Randall
NPI 1699766758
$3,092.40
in general payments reported to CMS, 2019-2025
8 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $667 · 2021: $898 · 2022: $290 · 2023: $417 · 2024: $268 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,373.80 | 2019-2025 | Eterna, Proclaim, Nt2000ix |
| Nevro Corp. | $224.62 | 2019-2024 | Senza |
| Medtronic, INC. | $162.42 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $120.82 | 2020-2023 | |
| Comsort, INC | $100.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $63.28 | 2025 | Belbuca |
| Nalu Medical, INC. | $28.59 | 2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $18.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Randall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.